Advanced

Functional analysis of BRCA1 C-terminal missense mutations identified in breast and ovarian cancer families

Vallon-Christersson, J LU ; Cayanan, C; Haraldsson, K LU ; Loman, N LU ; Bergthorsson, J T; Brøndum-Nielsen, K; Gerdes, A M; Møller, P; Kristoffersson, U LU and Olsson, Håkan LU , et al. (2001) In Human Molecular Genetics 10(4). p.60-353
Abstract

Germline mutations in the breast and ovarian cancer susceptibility gene BRCA1 are responsible for the majority of cases involving hereditary breast and ovarian cancer. Whereas all truncating mutations are considered as functionally deleterious, most of the missense variants identified to date cannot be readily distinguished as either disease-associated mutations or benign polymorphisms. The C-terminal domain of BRCA1 displays an intrinsic transactivation activity, and mutations linked to disease predisposition have been shown to confer loss of such activity in yeast and mammalian cells. In an attempt to clarify the functional importance of the BRCA1 C-terminus as a transcription activator in cancer predisposition, we have characterized... (More)

Germline mutations in the breast and ovarian cancer susceptibility gene BRCA1 are responsible for the majority of cases involving hereditary breast and ovarian cancer. Whereas all truncating mutations are considered as functionally deleterious, most of the missense variants identified to date cannot be readily distinguished as either disease-associated mutations or benign polymorphisms. The C-terminal domain of BRCA1 displays an intrinsic transactivation activity, and mutations linked to disease predisposition have been shown to confer loss of such activity in yeast and mammalian cells. In an attempt to clarify the functional importance of the BRCA1 C-terminus as a transcription activator in cancer predisposition, we have characterized the effect of C-terminal germline variants identified in Scandinavian breast and ovarian cancer families. Missense variants A1669S, C1697R, R1699W, R1699Q, A1708E, S1715R and G1738E and a truncating mutation, W1837X, were characterized using yeast- and mammalian-based transcription assays. In addition, four additional missense variants (V1665M, D1692N, S1715N and D1733G) and one in-frame deletion (V1688del) were included in the study. Our findings demonstrate that transactivation activity may reflect a tumor-suppressing function of BRCA1 and further support the role of BRCA1 missense mutations in disease predisposition. We also report a discrepancy between results from yeast- and mammalian-based assays, indicating that it may not be possible to unambiguously characterize variants with the yeast assay alone. We show that transcription-based assays can aid in the characterization of deleterious mutations in the C-terminal part of BRCA1 and may form the basis of a functional assay.

(Less)
Please use this url to cite or link to this publication:
author
, et al. (More)
(Less)
organization
publishing date
type
Contribution to journal
publication status
published
subject
keywords
Adult, Aged, Aged, 80 and over, Animals, BRCA1 Protein, Breast Neoplasms, Cell Line, Databases, Factual, Dogs, Exons, Female, Genes, BRCA1, Genetic Variation, Humans, Mice, Middle Aged, Mutation, Missense, Ovarian Neoplasms, Pedigree, Promoter Regions, Genetic, Rats, Recombinant Fusion Proteins, Transcriptional Activation
in
Human Molecular Genetics
volume
10
issue
4
pages
8 pages
publisher
Oxford University Press
external identifiers
  • pmid:11157798
  • wos:000167087800005
  • scopus:0035864827
ISSN
0964-6906
DOI
10.1093/hmg/10.4.353
language
English
LU publication?
yes
id
93a1c597-ebeb-484f-8494-677ad6a72f47 (old id 1120172)
date added to LUP
2008-07-17 09:18:37
date last changed
2018-10-03 10:06:51
@article{93a1c597-ebeb-484f-8494-677ad6a72f47,
  abstract     = {<p>Germline mutations in the breast and ovarian cancer susceptibility gene BRCA1 are responsible for the majority of cases involving hereditary breast and ovarian cancer. Whereas all truncating mutations are considered as functionally deleterious, most of the missense variants identified to date cannot be readily distinguished as either disease-associated mutations or benign polymorphisms. The C-terminal domain of BRCA1 displays an intrinsic transactivation activity, and mutations linked to disease predisposition have been shown to confer loss of such activity in yeast and mammalian cells. In an attempt to clarify the functional importance of the BRCA1 C-terminus as a transcription activator in cancer predisposition, we have characterized the effect of C-terminal germline variants identified in Scandinavian breast and ovarian cancer families. Missense variants A1669S, C1697R, R1699W, R1699Q, A1708E, S1715R and G1738E and a truncating mutation, W1837X, were characterized using yeast- and mammalian-based transcription assays. In addition, four additional missense variants (V1665M, D1692N, S1715N and D1733G) and one in-frame deletion (V1688del) were included in the study. Our findings demonstrate that transactivation activity may reflect a tumor-suppressing function of BRCA1 and further support the role of BRCA1 missense mutations in disease predisposition. We also report a discrepancy between results from yeast- and mammalian-based assays, indicating that it may not be possible to unambiguously characterize variants with the yeast assay alone. We show that transcription-based assays can aid in the characterization of deleterious mutations in the C-terminal part of BRCA1 and may form the basis of a functional assay.</p>},
  author       = {Vallon-Christersson, J and Cayanan, C and Haraldsson, K and Loman, N and Bergthorsson, J T and Brøndum-Nielsen, K and Gerdes, A M and Møller, P and Kristoffersson, U and Olsson, Håkan and Borg, Åke and Monteiro, A N},
  issn         = {0964-6906},
  keyword      = {Adult,Aged,Aged, 80 and over,Animals,BRCA1 Protein,Breast Neoplasms,Cell Line,Databases, Factual,Dogs,Exons,Female,Genes, BRCA1,Genetic Variation,Humans,Mice,Middle Aged,Mutation, Missense,Ovarian Neoplasms,Pedigree,Promoter Regions, Genetic,Rats,Recombinant Fusion Proteins,Transcriptional Activation},
  language     = {eng},
  month        = {02},
  number       = {4},
  pages        = {60--353},
  publisher    = {Oxford University Press},
  series       = {Human Molecular Genetics},
  title        = {Functional analysis of BRCA1 C-terminal missense mutations identified in breast and ovarian cancer families},
  url          = {http://dx.doi.org/10.1093/hmg/10.4.353},
  volume       = {10},
  year         = {2001},
}